POLR2A and cancer: In consequence, the present data show certain evidences that induced that the nuclear localization of CD26 by the humanized anti-CD26 mAb YS110 promotes transcriptional repression of the POLR2A gene, and then, the internalization of YS110-TR-1 compound into the nucleus may inhibit TFIIH, resulting in growth suppression of cancer cells.